SCHEMBL6714495

SCHEMBL6714495

Oc1nc2c[c]ccc2nc1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23844 0.78 MAPT (0.55)
SCHEMBL194246 0.76 MAPT (0.39)
SCHEMBL11227486 0.76 TDP1 (0.50)
SCHEMBL2401626 0.74 BCHE (0.31)
SCHEMBL193961 0.71 KMT2A (0.34)
SCHEMBL10674984 0.70
SCHEMBL15987437 0.70 KDM4E (0.50)
SCHEMBL8707994 0.69 MAOA (0.31)
SCHEMBL8719387 0.69 KMT2A (0.47)
SCHEMBL2478096 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040101523-A1 Renal-selective prodrugs for control of renal smpathetic nerve activity in the treatment of hypertension G.D. SEARLE & CO. 2004-05-27 US claimed
US-20030220521-A1 Renal-selective prodrugs for control of renal sympathetic nerve activity in the treatment of hypertension G.D. SEARLE & CO. 2003-11-27 US claimed
EP-0484437-A4 RENAL-SELECTIVE PRODRUGS FOR THE TREATMENT OF HYPERTENSION SEARLE & CO (US) 1994-06-01 EP claimed
EP-0484437-A1 RENAL-SELECTIVE PRODRUGS FOR THE TREATMENT OF HYPERTENSION G.D. Searle & Co. (US) 1992-05-13 EP claimed
WO-1992001667-A1 RENAL-SELECTIVE PRODRUGS FOR CONTROL OF RENAL SYMPATHETIC NERVE ACTIVITY IN THE TREATMENT OF HYPERTENSION G.D. SEARLE & CO. (US) 1992-02-06 WO claimed
WO-1991001724-A1 RENAL-SELECTIVE PRODRUGS FOR THE TREATMENT OF HYPERTENSION G.D. SEARLE & CO. (US) 1991-02-21 WO claimed
US-4775747-A PIGMENTS FOR POLYMERS CIBA-GEIGY CORPORATION (US) 1988-10-04 US claimed
US-20230310358-A1 Compositions And Methods For Treating Autism YAMO PHARMACEUTICALS LLC (US) 2023-10-05 US disclosed
CN-114901272-A Sustained release preparation 霍夫曼技术有限责任公司 2022-08-12 CN disclosed
US-20220211650-A1 SUSTAINED RELEASE FORMULATIONS HOFFMAN TECHNOLOGIES LLC 2022-07-07 US disclosed
EP-3955910-A1 SUSTAINED RELEASE FORMULATIONS Hoffman Technologies LLC. (US) 2022-02-23 EP disclosed
US-20210338619-A1 COMPOSITIONS AND METHODS FOR TREATING AUTISM YAMO PHARMACEUTICALS LLC 2021-11-04 US disclosed
EP-3823626-A1 COMPOSITIONS AND METHODS FOR TREATING AUTISM Yamo Pharmaceuticals LLC (US) 2021-05-26 EP disclosed
EP-0092830-A2 Cephalosporin derivatives, process for their preparation, pharmaceutical compositions containing them and their application CIBA-GEIGY AG (CH) 1983-11-02 EP disclosed
US-4271187-A Substituted phenyl alanine antihypertensive agents MERCK & CO., INC. (US) 1981-06-02 US disclosed
US-4206216-A Antihypertensive N-heterocyclicalanines MERCK & CO., INC. (US) 1980-06-03 US disclosed
US-4160835-A Antihypertensive compositions containing an arylsubstituted alanine and a phenyl hydrazinopropionic acid MERCK & CO., INC. (US) 1979-07-10 US disclosed
US-4156734-A Antihypertensive compositions containing an aryl-substituted alanine azo and an arylhydrazino-propionic acid MERCK & CO., INC. (US) 1979-05-29 US disclosed
US-4153715-A Indolyl amino acids useful as antihypertensive agents MERCK & CO., INC. (US) 1979-05-08 US disclosed
US-4065572-A Amino acids and esters thereof useful as antihypertensive agents MERCK & CO., INC. (US) 1977-12-27 US disclosed